Secondaries Announced 3.22.18

IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis.

If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today!

Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis. For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is a short term (usually one day or opening trade) time period.

Company: Leap Therapeutics
Symbol: LPTX
Price: Last Trade $8.20
Trade Date: 3/23
Shares: 1.7 million ($14 million cash raise)
Re-Offer Range: Subscription Needed
Underwriter(s): Raymond James, Ladenburg Thalmann
Description: They are focused on developing targeted and immuno-oncology therapeutics.
Rating = Subscription Needed

Company: Akebia Therapeutics, Inc.-BLOCK
Symbol: AKBA
Price: Last Trade $11.68
Trade Date: 3/23
Shares: 7.3 million ($85 million cash raise)
Re-Offer Range: Subscription Needed
Underwriter(s): Morgan Stanley
Description: Akebia Therapeutics, Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on delivering innovative therapies to patients with kidney disease through hypoxia-inducible factor biology.
Rating = Subscription Needed